Rohan Goswami, MD
Advanced Heart Failure and Transplant Cardiology · Jacksonville, FLNPI 1770870453
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $85,950 of the $111,902 with a category attached, or 76.8%. Abiomed accounts for 94.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $54,028 and has fallen 78.0% since, to $11,884 in 2025.
Across 82 payments — averaging $1364.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$106K
- Cvrx, Inc.$6K
- Abbott$431
- One Lambda, Inc.$51
What the payments were for
- Consulting fees$7,5007%
- Speaking & faculty fees$85,95077%
- Travel & lodging$15,41714%
- Food & beverage$3,0363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 61 | $105,860 |
| Cvrx, Inc. | 17 | $5,559 |
| Abbott | 3 | $431 |
| One Lambda, Inc. | 1 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$94,006
- Barostim Neo System$5,290
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$256
- Attune Flex Adj Annuloplasty Rng$175
How this compares
$111,902 in reported general payments places this provider in the 85th percentile of 48 advanced heart failure and transplant cardiology providers in Florida.
See all advanced heart failure and transplant cardiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 17 | $17,477 |
| EliquisApixaban | 20 | $11,738 |
| Tacrolimus | 17 | $4,602 |
| Mycophenolate Mofetil | 15 | $1,528 |
| Bumetanide | 32 | $1,178 |
| Spironolactone | 38 | $391 |
| Metoprolol Succinate | 29 | $362 |
| Pravastatin Sodium | 38 | $361 |
| Propranolol Hcl | 19 | $291 |
| Atorvastatin Calcium | 24 | $249 |
| Losartan Potassium | 21 | $226 |
| Omeprazole | 14 | $184 |
| Pantoprazole Sodium | 34 | $158 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $129 |
| Carvedilol | 38 | $116 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Jacksonville
- Grace LinJacksonville$5K
- Parag PatelJacksonville$4K
- Melissa LyleJacksonville$2K
- Juan Carlos Leoni MorenoJacksonville$1K
- Devora LeventhalJacksonville$688
- Ravi KumarJacksonville$148
- Daniel YipJacksonville$123
- Kelly McCantsWinter Park$445K
- Naveen BellamOrlando$414K
- Phillip HabibDelray Beach$305K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.